AU2002342250A1 - Use of casb 7439 for treatment and diagnosis of lung cancer - Google Patents

Use of casb 7439 for treatment and diagnosis of lung cancer

Info

Publication number
AU2002342250A1
AU2002342250A1 AU2002342250A AU2002342250A AU2002342250A1 AU 2002342250 A1 AU2002342250 A1 AU 2002342250A1 AU 2002342250 A AU2002342250 A AU 2002342250A AU 2002342250 A AU2002342250 A AU 2002342250A AU 2002342250 A1 AU2002342250 A1 AU 2002342250A1
Authority
AU
Australia
Prior art keywords
casb
diagnosis
treatment
lung cancer
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002342250A
Inventor
Thierry Coche
Swann Romain Jean-Thomas Gaulis
Carlotta Vinals Y De Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of AU2002342250A1 publication Critical patent/AU2002342250A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002342250A 2001-05-16 2002-05-07 Use of casb 7439 for treatment and diagnosis of lung cancer Abandoned AU2002342250A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0111974.2 2001-05-16
GBGB0111974.2A GB0111974D0 (en) 2001-05-16 2001-05-16 Novel Compounds
PCT/EP2002/005011 WO2002092627A2 (en) 2001-05-16 2002-05-07 Use of casb 7439 for treatment and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
AU2002342250A1 true AU2002342250A1 (en) 2002-11-25

Family

ID=9914758

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342250A Abandoned AU2002342250A1 (en) 2001-05-16 2002-05-07 Use of casb 7439 for treatment and diagnosis of lung cancer

Country Status (3)

Country Link
AU (1) AU2002342250A1 (en)
GB (1) GB0111974D0 (en)
WO (1) WO2002092627A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA020617B1 (en) 2009-05-27 2014-12-30 Глаксосмитклайн Байолоджикалс С.А. Casb7439 constructs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235474B1 (en) * 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
AU5788900A (en) * 1999-07-07 2001-01-22 Tularik Inc. Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides
CA2400842C (en) * 2000-02-23 2013-01-15 Smithkline Beecham Biologicals S.A. Novel compounds
GB0104259D0 (en) * 2001-02-21 2001-04-11 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
WO2002092627A2 (en) 2002-11-21
GB0111974D0 (en) 2001-07-04
WO2002092627A3 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001249493A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase